文献速递肝胆胰外科围术期管理与 ERAS

术前门静脉栓塞后仍发生术后肝功能不全:不只看体积

Postoperative hepatic insufficiency despite preoperative portal vein embolization: Not just about the volumetrics.
PubMed 文献 · Surgery · 2025-03-28

多中心回顾性研究纳入164例术前门静脉栓塞后行大范围肝切除术患者,12%发生术后肝功能不全(胆红素峰值>7 mg/dL)。多因素分析显示胆管癌/胆囊癌诊断和术前胆管炎为独立危险因素,而未来残肝体积指标无独立关联。术后肝功能不全使90天死亡率从3.5%升至45%,住院时间从7天延长至16天。

要点

  • 门静脉栓塞后大范围肝切除仍约12%发生术后肝功能不全,体积增生充分不等于安全。
  • 胆管癌/胆囊癌和术前胆管炎是术后肝功能不全的独立预测因素,需术前重点评估。
  • 术后肝功能不全显著升高90天死亡率(45% vs 3.5%)并延长住院时间。

核心结论

  • 术前门静脉栓塞后大范围肝切除患者中12%仍发生术后肝功能不全,胆管癌/胆囊癌和术前胆管炎为独立预测因素。

研究设计与样本

  • 6家学术医学中心回顾性研究,2008至2019年共164例术前门静脉栓塞后行大范围肝切除术患者。

主要发现

  • 20例(12%)发生术后肝功能不全,定义为术后胆红素峰值>7 mg/dL。
  • 术后肝功能不全组90天死亡率为45%,无术后肝功能不全组为3.5%(P < .001)。
  • 术后肝功能不全组住院时间16天,无术后肝功能不全组7天(P < .001)。
  • 单因素分析中术后肝功能不全与高龄、体能状态、术前胆道引流、较小残肝体积、胆管癌/胆囊癌及术前胆管炎相关。
  • 即使发生术后肝功能不全,残肝体积仍从27%增至39%,增生程度>5%和动态增长率>2%/周在两组间无差异(P = .6和P = .3)。

关键数值与推荐

  • 多因素分析中胆管癌/胆囊癌诊断和术前胆管炎为术后肝功能不全独立危险因素,残肝体积指标无独立关联。
  • 胆管癌/胆囊癌患者术后肝功能不全发生率为34%,术前胆管炎患者为62%。

临床怎么用

  • 对计划门静脉栓塞后大范围肝切除患者,除评估残肝体积外,应重点关注胆管癌/胆囊癌诊断和术前胆管炎。
  • 合并术前胆管炎或胆管癌/胆囊癌者术后肝功能不全风险高,需加强围术期监测与预案。

局限性

  • 回顾性研究设计,样本量164例,术后肝功能不全事件仅20例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Future liver remnant hypertrophy is the primary endpoint of portal vein embolization before major hepatectomy. However, even when adequate future liver remnant is achieved, postoperative hepatic insufficiency is not universally averted. We aimed to identify preoperative risk factors of postoperative hepatic insufficiency despite the use of portal vein embolization. METHODS: Patients who underwent portal vein embolization followed by major hepatectomy at 6 academic medical centers were retrospectively reviewed. Postoperative hepatic insufficiency was defined as postoperative peak bilirubin >7 mg/dL. Preoperative variables associated with postoperative hepatic insufficiency were analyzed. RESULTS: From 2008 to 2019, 164 patients underwent portal vein embolization followed by major hepatectomy. Twenty (12%) patients developed postoperative hepatic insufficiency. On univariate analysis, postoperative hepatic insufficiency was associated with older age, performance status, preoperative biliary drainage, smaller pre- and post-portal vein embolization future liver remnant volumes, diagnosis of cholangiocarcinoma/gallbladder cancer, and preoperative cholangitis. There was significant future liver remnant hypertrophy noted even in the setting of postoperative hepatic insufficiency (from 27% to 39%); however, degree of hypertrophy >5% (100% vs 93%, P = .6) and kinetic growth rate >2%/week (95% vs 82%, P = .3) did not differ between the postoperative hepatic insufficiency and non-postoperative hepatic insufficiency groups. On multivariate analysis, the diagnosis of cholangiocarcinoma/gallbladder cancer and preoperative cholangitis (postoperative hepatic insufficiency incidence 34% and 62%, respectively), but not future liver remnant volumetrics, were independently associated with postoperative hepatic insufficiency. Postoperative hepatic insufficiency raised post-hepatectomy 90-day mortality from 3.5% to 45% and hospitalization from 7 days to 16 days (both P < .001). CONCLUSION: Postoperative hepatic insufficiency still occurs in 12% of patients after major hepatectomy despite preoperative portal vein embolization. In addition to traditional volumetric information, surgeons should be aware of preoperative cholangitis and cholangiocarcinoma/gallbladder cancer as powerful predictors of this fatal complication.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Li AY, Ahmad MU, Sofilos MC, et al. Postoperative hepatic insufficiency despite preoperative portal vein embolization: Not just about the volumetrics. Surgery. 2025. PMID: 40157125. doi:10.1016/j.surg.2025.109345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。